Product image of Oleunor Mit Elektrolyten (Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac) supplied by GNH India

Oleunor Mit Elektrolyten

Active Ingredient:
Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac
Origin:
EU

Oleunor Mit Elektrolyten (Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac)

Glycine, the active ingredient in Oleunor Mit Elektrolyten, is an electrolyte solution presented as a sterile intravenous solution for injection use. Combined with magnesium chloride, potassium chloride, calcium chloride and L‑lysine, it helps replace depleted electrolytes and correct acid‑base disturbances in patients requiring fluid therapy.

GNH India supplies Oleunor Mit Elektrolyten as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Noridem Enterprises Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Oleunor Mit Elektrolyten is an intravenous electrolyte solution used to address conditions involving electrolyte loss and fluid imbalance.
  • Electrolyte depletion: restores plasma levels of magnesium, potassium, calcium and other essential ions.
  • Fluid and electrolyte replacement therapy: supports volume expansion and maintains osmotic balance during surgery or critical illness.
  • Metabolic acidosis: provides glycine and electrolytes that aid in correcting acid‑base disturbances.

How It Works

  • The solution delivers glycine together with magnesium, potassium, calcium and lysine directly into the bloodstream. These ions are rapidly distributed into the extracellular fluid, re‑establishing normal plasma electrolyte concentrations, supporting enzymatic reactions, stabilising cell membranes and contributing to the regulation of acid‑base balance.

Side Effects

Oleunor Mit Elektrolyten may be associated with the following adverse reactions.

Common Side Effects

  • Local irritation at the infusion site.
  • Mild nausea or vomiting.
  • Transient headache.
  • Temporary increase in serum calcium levels.
  • Mild hypermagnesemia.
  • Slight elevation of serum potassium.

Serious or Rare Side Effects

  • Severe hyperkalemia leading to cardiac arrhythmia.
  • Hypermagnesemia causing respiratory depression.
  • Hypercalcemia with neuromuscular symptoms.
  • Anaphylactic reaction to any component.
  • Severe electrolyte imbalance requiring intensive monitoring.

Precautions & Warnings

  • When using Oleunor Mit Elektrolyten, consider the following precautions.
  • Assess baseline electrolyte levels: obtain serum magnesium, potassium, calcium and glycine before infusion.
  • Monitor cardiac function: especially in patients with pre‑existing heart disease.
  • Adjust dose in renal impairment: reduced clearance may increase electrolyte concentrations.
  • Avoid rapid infusion: administer at recommended rate to prevent circulatory overload.
  • Pregnancy and lactation: use only if clearly needed and under specialist supervision.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the container.

Avoid Interactions

Oleunor Mit Elektrolyten can interact with other medications affecting electrolyte balance.

Major Interactions (Avoid)

  • Calcium channel blockers: may potentiate hypercalcemia.
  • Potassium‑sparing diuretics: increase risk of severe hyperkalemia.
  • Magnesium‑containing antacids: can cause excessive magnesium levels.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: monitor potassium and renal function.
  • Loop diuretics: may require adjustment of electrolyte supplementation.
  • Certain antibiotics (e.g., aminoglycosides): watch for nephrotoxic effects with electrolyte shifts.

Frequently Asked Questions

Oleunor Mit Elektrolyten is an intravenous electrolyte solution used to replace lost electrolytes such as magnesium, potassium, calcium and to correct acid‑base disturbances in patients who have experienced electrolyte depletion or require fluid and electrolyte replacement therapy.

Glycine in Oleunor Mit Elektrolyten acts as a buffering agent and contributes to the restoration of normal plasma pH. Together with the supplied electrolytes, it helps stabilise cell membranes and supports enzymatic processes that are essential for maintaining physiological homeostasis.

The dose of Oleunor Mit Elektrolyten is determined by the prescribing clinician based on the patient’s electrolyte status, fluid needs and clinical condition. The healthcare professional will calculate the appropriate volume and infusion rate for each individual case.

Safety in pregnancy or lactation has not been fully established. The product should only be used when clearly needed and under the supervision of a qualified obstetric or neonatal specialist, weighing potential benefits against any possible risks.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and necessary import documentation.

Oleunor Mit Elektrolyten offers a combination of glycine, magnesium, potassium, calcium and lysine in a single sterile IV formulation, providing a broader electrolyte profile than many single‑ion solutions. This may reduce the need for multiple infusions, but selection should be based on the specific electrolyte deficits of the patient.

The product should be stored at 2‑8 °C, kept refrigerated, protected from light and never frozen. Do not shake the container vigorously; allow it to reach room temperature before administration if required by the clinical protocol.

Oleunor Mit Elektrolyten is administered intravenously. The solution is typically infused through a peripheral or central line at a rate prescribed by the clinician, using aseptic technique and appropriate infusion equipment to ensure accurate delivery.

Serious risks include severe hyperkalemia, hypermagnesemia or hypercalcemia, which can lead to cardiac arrhythmias, respiratory depression or neuromuscular disturbances. Anaphylactic reactions to any component are also possible and require immediate medical attention.

Patients with known hypersensitivity to any of the ingredients, those with uncontrolled severe electrolyte imbalances, or individuals for whom rapid infusion could cause circulatory overload should not receive Oleunor Mit Elektrolyten unless a specialist determines it is safe.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT